Jang-Hwan Cho

Oncology · 2018

A researcher in the Science corpus: 1 paper; trusts 9 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom Jang-Hwan Cho trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michel Sadelain
  2. Lieping Chen
  3. Kole T. Roybal
  4. D. Vignali
  5. I. Rivière
  6. É. Vivier
  7. S. Maude
  8. D. Flies
  9. R. Brentjens
  10. L. Collison

Who trusts Jang-Hwan Cho overall

  1. S. Rafiq
  2. Christopher S. Hackett

Papers from Jang-Hwan Cho's perspective

Ordered by how strongly the researchers Jang-Hwan Cho trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (New England Journal of Medicine)
  2. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (Science Translational Medicine)
  3. Molecular mechanisms of T cell co-stimulation and co-inhibition (Nature reviews. Immunology)
  4. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  5. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  6. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (New England Journal of Medicine)
  7. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. (Blood)
  8. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. (Journal of Clinical Investigation)
  9. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy (New England Journal of Medicine)
  10. Precision Tumor Recognition by T Cells With Combinatorial Antigen Sensing Circuits (Cell)

Their papers